Monitoring treatment in pediatric patients with 21-hydroxylase deficiency

21-hydroxylase deficiency (21-OHD) is the most common form of congenital adrenal hyperplasia. In most developed countries, newborn screening enables diagnosis of 21-OHD in asymptomatic patients during the neonatal period. In addition, recent advances in genetic testing have facilitated diagnosing 21...

Descripción completa

Detalles Bibliográficos
Autores principales: Itonaga, Tomoyo, Hasegawa, Yukihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945343/
https://www.ncbi.nlm.nih.gov/pubmed/36843618
http://dx.doi.org/10.3389/fendo.2023.1102741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945343/
https://www.ncbi.nlm.nih.gov/pubmed/36843618
http://dx.doi.org/10.3389/fendo.2023.1102741

Ejemplares similares